Ep. 270 - Temple’s FDA Legacy. Plus: Chinese Innovation & Novo Obesity Data
30 Dec 2024
34m
BioCentury · Business
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Episodes
Bonus Content - Trends in Global Biopharma Deals: Lazard’s Kingston and Raine
23 Dec 2024
34m
Ep. 269 - Trends in VC Funds, Obesity Start-ups and More
17 Dec 2024
33m
Ep. 268 - Biosecure Setback & Novartis' $1B PTC Deal
10 Dec 2024
21m
Ep. 267 - Trump's NIH Pick & Multi-targeted CAR Ts
03 Dec 2024
27m
Ep. 266 - Jefferies Recap, FDA Commissioner & Biosecure Update
26 Nov 2024
26m
Ep. 265 - RFK Jr. & HHS, Blenrep's Comeback, China Deals
19 Nov 2024
29m
Ep. 264 - Prepping for Trump & Alzheimer's Ethics
12 Nov 2024
29m
Ep. 263 - Alzheimer insights: Anti-amyloid safety and a tau teaser
05 Nov 2024
34m
Ep. 262 - EGFR Case Study, FDA & Politics
29 Oct 2024
23m
Ep. 261 - China Summit: Reinventing Your China Strategy
24 Oct 2024
31m
Ep. 260 - VC Funds, New Chapter for MS, Wave's Data
22 Oct 2024
31m
Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA
15 Oct 2024
33m
Ep. 258 - Breaking the Bear: 4Q Public Markets Preview
08 Oct 2024
39m
Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
01 Oct 2024
32m
Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary
26 Sep 2024
26m
Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss
24 Sep 2024
21m
Ep. 254 - Takeaways from Grand Rounds 2024
20 Sep 2024
34m
Ep. 253 - IPOs, GLP-1 & Obesity, AI & Biotech
17 Sep 2024
32m
Ep. 252 - Akeso's Bispecific, Vaxcyte & Woodcock's Quality Mindset
10 Sep 2024
18m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.